panderm cream 10.000000 iu/100g, 0.025 g/100g, 0.25 g/100g, 0.1 g/100g
مستودع الأدوية المهني - professional drug store - nystatin 10.000000 iu/100g, gramicidin 0.025 g/100g, neomycin 0.25 g/100g, triamcinolone acetonide 0.1 g/100g - 10.000000 iu/100g, 0.025 g/100g, 0.25 g/100g, 0.1 g/100g
panderm cream 10.000000 iu/100g, 0.025 g/100g, 0.25 g/100g, 0.1 g/100g
مستودع الأدوية المهني - professional drug store - nystatin 10.000000 iu/100g, gramicidin 0.025 g/100g, neomycin 0.25 g/100g, triamcinolone acetonide 0.1 g/100g - 10.000000 iu/100g, 0.025 g/100g, 0.25 g/100g, 0.1 g/100g
renebo 0.225 g/15gm, 0.225 g/15gm, 0.15 g/15gm
الشركة الدولية للدواء - pharma international company - radix scutellaria crude powder 0.225 g/15gm, cortex phellodendri crude powder 0.225 g/15gm, rhizoma coptidis crude powder 0.15 g/15gm - 0.225 g/15gm, 0.225 g/15gm, 0.15 g/15gm
renebo 0.1875 g/75gm, 1.125 g/75gm, 1.125 g/75gm, 0.75 g/75gm
الشركة الدولية للدواء - pharma international company - b-sitosterol 0.1875 g/75gm, radix scutellaria crude powder 1.125 g/75gm, cortex phellodendri crude powder 1.125 g/75gm, rhizoma coptidis crude powder 0.75 g/75gm - 0.1875 g/75gm, 1.125 g/75gm, 1.125 g/75gm, 0.75 g/75gm
yanoven 2g + 0.25g vial 2 g, 0.25 g
مستودع ادوية أدونيس - adonis drug store - piperacillin 2 g, tazobactam 0.25 g - 2 g, 0.25 g
lysakare solution for infusion 25g 25g
novartis (singapore) pte ltd - l-arginine hydrochloride; l-lysine hydrochloride - infusion, solution - l-arginine hydrochloride 25 g/l; l-lysine hydrochloride 25 g/l
piperacillin/tazobactam 2.25g injection 0.25 g, 2 g
مستودع ادوية النابلسي - nabulsi drug store - tazobactam 0.25 g, piperacillin monohydrate 2 g - 0.25 g, 2 g
emoflon™ rectal ointment 0.75 g/ 25 g
modern pharmaceutical company hungary - 25 g aluminium tube with applicator - ointment - 0.75 g/ 25 g - medical devices-medical devices
dermoplex cream 3g/4g/25g cream
ccm international (philippines), inc - zinc oxide , calamine - cream - 3g/4g/25g
tazopip 2 g/0.25 g piperacillin (as sodium) 2 g and tazobactam (as sodium) 0.25 g powder for injection vial
alphapharm pty ltd - piperacillin sodium, quantity: 2.1 g (equivalent: piperacillin, qty 2 g); tazobactam sodium, quantity: 0.27 g (equivalent: tazobactam, qty 0.25 g) - injection, powder for - excipient ingredients: - tazopip is indicated in the treatment of serious bacterial infections caused by susceptible strains of beta -lactamase producing organisms in the conditions as listed: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated). 3.intra- abdominal infections. 4. skin and skin structure infections. 5. bacterial septicaemia. 6. gynaecological infections. children under the age of 12 years: in hospitalised children aged 2 to 12 years, tazopip is indicated for the treatment of serious intra-abdominal infections. it has not been evaluated in this indication for paediatric patients below the age of 2 years. while tazopip is indicated only for the conditions listed above, it may be used as a single agent in the treatment of mixed infections caused by piperacillin susceptible and beta -lactamase producing piperacillin-resistant organisms. appropriate culture and susceptibility tests should be performed before treatment in order to identify organisms causing infection to determine their susceptibilities to tazopip. therapy with tazopip may be initiated before results of such tests are known when there is a reason to believe the infection may involve any of the beta -lactamase producing organisms listed above. however, once these results become available, appropriate therapy should be continued. in serious infections, presumptive therapy with tazopip may be initiated before susceptibility test results are available. combination therapy with tazopip and aminoglycosides may be used in the treatment of serious infections caused by pseudomonas aeruginosa. both drugs should be used in full therapeutic doses. as soon as results of culture and susceptibility tests become available, antimicrobial therapy should be adjusted.